Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) traded up 1.3% during mid-day trading on Friday . The company traded as high as GBX 8 ($0.10) and last traded at GBX 7.60 ($0.10). 578,419 shares changed hands during mid-day trading, an increase of 160% from the average session volume of 222,213 shares. The stock had previously closed at GBX 7.50 ($0.09).
Abingdon Health Stock Up 1.3 %
The company has a fifty day moving average of GBX 8.72 and a 200 day moving average of GBX 9.82. The company has a market cap of £14.40 million, a P/E ratio of -899.00 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- Most active stocks: Dollar volume vs share volume
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Time to Load Up on Home Builders?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
